← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vasade Biosciences, Inc.
Barnegat Light, NJ
$6,370,094
Total funding
11
Grants
Funding over time
peak $856.6K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,370,094 · 11
By mechanism
R44$3,387,234 · 2
R42$1,883,238 · 2
R41$799,501 · 5
R43$300,121 · 2
Investigators at Vasade Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
AC5 inhibitor for heart failure$856,579
R44 · FY2014 · HL
AC5 inhibitor for heart failure$764,406
R44 · FY2013 · HL
Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction$715,042
R44 · FY2020 · HL
Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction$673,385
R44 · FY2019 · HL
Prevention of Cardiac Cell Death by Mst1 inhibitor$556,030
R42 · FY2011 · HL
Prevention of Cardiac Cell Death by Mst1 inhibitor$551,157
R42 · FY2010 · HL
Primate Model for Pharmaceutical Development$393,566
R42 · FY2007 · HL
Primate Model for Pharmaceutical Development$382,485
R42 · FY2008 · HL
A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease$252,130
R41 · FY2023 · AG
AC5 inhibitor for heart failure$205,669
R44 · FY2012 · HL
Adenylyl Cyclase Type 5 Inhibition to Treat Myocardial Infarction$172,153
R44 · FY2018 · HL
Acute Coronary Syndrome animal model$167,930
R43 · FY2012 · HL
Prevention of neointimal thickening by Mst1$145,499
R41 · FY2006 · HL
Prevention of cardiac cell death by Mst1 inhibitor$141,802
R41 · FY2005 · HL
AC5 Inhibitor for Obesity$133,845
R41 · FY2010 · DK
AntimiR-199a for cardiac ischemia and failure$132,191
R43 · FY2010 · HL
Primate Model for Pharmaceutical Development$126,225
R41 · FY2005 · HL